Release Date: 05/05/17 10:03 Summary: Response to Cobaltech TSX Announcement Price Sensitive: Yes Download Document 238.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%